BeiGene to Present at Upcoming Investor Conferences

CAMBRIDGE, Mass., June 07, 2017 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ: BGNE), a clinical-stage biopharmaceutical company developing innovative molecularly targeted and immuno-oncology drugs for the treatment of cancer, today announced that the company will present at the following upcoming investor conferences:

William Blair 37th Annual Growth Stock ConferenceDate: Tuesday, June 13, 2017Time: 12:50 PM CT (1:50 PM ET)Location: Chicago, IL

Goldman Sachs 38th Annual Global Healthcare ConferenceDate: Tuesday, June 13, 2017Time: 2:40 PM PT (5:40 PM ET)Location: Ranchos Palos Verdes, CA

Live webcasts of the presentations can be accessed from the investors section of BeiGene’s website at http://ir.beigene.com/. An archived replay will be available for 90 days following the event.

About BeiGene

BeiGene is a global, clinical-stage, research-based biotechnology company focused on molecularly targeted and immuno-oncology cancer therapeutics. With a team of over 400 employees in mainland China, the United States, and Australia, BeiGene is advancing a pipeline consisting of novel oral small molecules and monoclonal antibodies for the treatment of cancer. BeiGene is working to create combination solutions aimed at having both a meaningful and lasting impact on cancer patients.

Investor/Media Contact
Lucy Li, Ph.D.
+1 781-801-1800
[email protected]
[email protected]

You May Also Be Interested In

• William Blair Upgrades Moderna (MRNA) to Outperform, 'we believe Moderna has a clear line of sight to revenue diversification from the COVID business
• reVolver Podcasts Launches Match o Menos, a New Spanish-Language Comedy Podcast Starring Master Impressionist Camilo Cifuentes
• From the Classroom to the Field: Salem State University's Humanities Brigade Reports After First Year